SYK: Stryker Corporation - Summary | Jitta

Stryker Corporation

NYSE:SYK

Price
$347.56
Loss Chance
45.2%
6.58JITTA SCORE
232.75%Over Jitta Line
Jitta Ranking
69 / 1,129
892 / 4,931
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (66)
Recent Business Performance (79)
Financial Strength (79)
Return to Shareholders (75)
Competitive Advantage (68)
Jitta Signs
Revenue and EarningConsistent Growth in the past 3 years
Recent Business PerformanceEarning Growth Last Quarter (YoY)
Dividend PayoutIncreasing Every Year
CapExVery Low
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
6.58
232.75%
2.06
253.04%
Health Care Equipment
4.92
21.74%
5.37
14.43%
5.48
40.37%
COMPANY DESCRIPTION
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.